Literature DB >> 32883935

Genomic evolution of severe acute respiratory syndrome Coronavirus 2 in India and vaccine impact.

Jobin John Jacob1, Karthick Vasudevan1, Balaji Veeraraghavan2, Ramya Iyadurai3, Karthik Gunasekaran3.   

Abstract

Recent emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and subsequent containment procedures have impacted the world as never seen before. Therefore, there is considerable curiosity about the genome evolution related to the origin, transmission and vaccine impact of this virus. We have analysed genome sequences of SARS-CoV-2 isolated from Indian patients to gain an in-depth understanding of genomic evolution and transmission in India. Phylogenetic analysis and mutation profiling revealed major lineages being evolved by characteristic mutations. As the mutation frequency in spike protein is comparatively lesser, the candidate vaccines expected to have wide coverage worldwide including India.

Entities:  

Keywords:  COVID-19; India; evolution; severe acute respiratory syndrome coronavirus 2; transmission; vaccine

Mesh:

Substances:

Year:  2020        PMID: 32883935      PMCID: PMC7709607          DOI: 10.4103/ijmm.IJMM_20_303

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  13 in total

1.  Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.

Authors:  Ning Tang; Huan Bai; Xing Chen; Jiale Gong; Dengju Li; Ziyong Sun
Journal:  J Thromb Haemost       Date:  2020-04-27       Impact factor: 5.824

2.  Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)?

Authors:  Ping Liu; Jing-Zhe Jiang; Xiu-Feng Wan; Yan Hua; Linmiao Li; Jiabin Zhou; Xiaohu Wang; Fanghui Hou; Jing Chen; Jiejian Zou; Jinping Chen
Journal:  PLoS Pathog       Date:  2020-05-14       Impact factor: 6.823

3.  Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event.

Authors:  D Paraskevis; E G Kostaki; G Magiorkinis; G Panayiotakopoulos; G Sourvinos; S Tsiodras
Journal:  Infect Genet Evol       Date:  2020-01-29       Impact factor: 3.342

4.  A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.

Authors:  David R Boulware; Matthew F Pullen; Ananta S Bangdiwala; Katelyn A Pastick; Sarah M Lofgren; Elizabeth C Okafor; Caleb P Skipper; Alanna A Nascene; Melanie R Nicol; Mahsa Abassi; Nicole W Engen; Matthew P Cheng; Derek LaBar; Sylvain A Lother; Lauren J MacKenzie; Glen Drobot; Nicole Marten; Ryan Zarychanski; Lauren E Kelly; Ilan S Schwartz; Emily G McDonald; Radha Rajasingham; Todd C Lee; Kathy H Hullsiek
Journal:  N Engl J Med       Date:  2020-06-03       Impact factor: 91.245

5.  Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19.

Authors:  Emily C Somers; Gregory A Eschenauer; Jonathan P Troost; Jonathan L Golob; Tejal N Gandhi; Lu Wang; Nina Zhou; Lindsay A Petty; Ji Hoon Baang; Nicholas O Dillman; David Frame; Kevin S Gregg; Dan R Kaul; Jerod Nagel; Twisha S Patel; Shiwei Zhou; Adam S Lauring; David A Hanauer; Emily Martin; Pratima Sharma; Christopher M Fung; Jason M Pogue
Journal:  Clin Infect Dis       Date:  2021-07-15       Impact factor: 9.079

6.  A Distinct Phylogenetic Cluster of Indian Severe Acute Respiratory Syndrome Coronavirus 2 Isolates.

Authors:  Sofia Banu; Bani Jolly; Payel Mukherjee; Priya Singh; Shagufta Khan; Lamuk Zaveri; Sakshi Shambhavi; Namami Gaur; Shashikala Reddy; K Kaveri; Sivasubramanian Srinivasan; Dhinakar Raj Gopal; Archana Bharadwaj Siva; Kumarasamy Thangaraj; Karthik Bharadwaj Tallapaka; Rakesh K Mishra; Vinod Scaria; Divya Tej Sowpati
Journal:  Open Forum Infect Dis       Date:  2020-09-18       Impact factor: 3.835

7.  Epidemic Landscape and Forecasting of SARS-CoV-2 in India.

Authors:  Aravind Lathika Rajendrakumar; Anand Thakarakkattil Narayanan Nair; Charvi Nangia; Prabal Kumar Chourasia; Mehul Kumar Chourasia; Mohammed Ghouse Syed; Anu Sasidharan Nair; Arun B Nair; Muhammed Shaffi Fazaludeen Koya
Journal:  J Epidemiol Glob Health       Date:  2020-08-28

8.  The proximal origin of SARS-CoV-2.

Authors:  Kristian G Andersen; Andrew Rambaut; W Ian Lipkin; Edward C Holmes; Robert F Garry
Journal:  Nat Med       Date:  2020-04       Impact factor: 87.241

9.  SARS-CoV-2 viral spike G614 mutation exhibits higher case fatality rate.

Authors:  Manuel Becerra-Flores; Timothy Cardozo
Journal:  Int J Clin Pract       Date:  2020-06-03       Impact factor: 3.149

10.  Emergence of SARS-CoV-2 through recombination and strong purifying selection.

Authors:  Xiaojun Li; Elena E Giorgi; Manukumar Honnayakanahalli Marichannegowda; Brian Foley; Chuan Xiao; Xiang-Peng Kong; Yue Chen; S Gnanakaran; Bette Korber; Feng Gao
Journal:  Sci Adv       Date:  2020-07-01       Impact factor: 14.957

View more
  2 in total

Review 1.  A review of novel coronavirus disease (COVID-19): based on genomic structure, phylogeny, current shreds of evidence, candidate vaccines, and drug repurposing.

Authors:  S Udhaya Kumar; N Madhana Priya; S R Nithya; Priyanka Kannan; Nikita Jain; D Thirumal Kumar; R Magesh; Salma Younes; Hatem Zayed; C George Priya Doss
Journal:  3 Biotech       Date:  2021-03-27       Impact factor: 2.406

2.  Phylodynamic Pattern of Genetic Clusters, Paradigm Shift on Spatio-Temporal Distribution of Clades, and Impact of Spike Glycoprotein Mutations of SARS-CoV-2 Isolates from India.

Authors:  Srinivasan Sivasubramanian; Vidya Gopalan; Kiruba Ramesh; Padmapriya Padmanabhan; Kiruthiga Mone; Karthikeyan Govindan; Selvakumar Velladurai; Prabu Dhandapani; Kaveri Krishnasamy; Satish Srinivas Kitambi
Journal:  J Glob Infect Dis       Date:  2021-11-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.